Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C van der Horst

Showing results (151-160 of 402) with videos related to

Pageof 41
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000
A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individualsC M Marra, P Boutin, J C McArthur, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 3, 2008
Hybrid approach for complex coronary artery and valve disease: a clinical follow-up studyJ O J Peels, G A J Jessurun, P W Boonstra, et al.
Critical Care (London, England)|July 13, 2006
Hyperglycaemia in critically ill patients: marker or mediator of mortality?Anouk M Corstjens, Iwan C C van der Horst, Jan G Zijlstra, et al.
Immunologic Research|January 19, 2022
Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroupsT Tomassen, M E Weidema, M H S Hillebrandt-Roeffen, et al.
International Journal of Cardiology|January 16, 2007
One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The Glucose-insulin-potassium study IISaman Rasoul, Jan Paul Ottervanger, Jorik R Timmer, et al.
BMJ (Clinical Research Ed.)|July 5, 2022
Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysisRuben J Eck, Tessa Elling, Alex J Sutton, et al.
American Heart Journal|July 2, 2005
Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2)Iwan C C van der Horst, Jorik R Timmer, Jan Paul Ottervanger, et al.
Intensive Care Medicine|February 16, 2006
Mean glucose level is not an independent risk factor for mortality in mixed ICU patientsJack J M Ligtenberg, Sofie Meijering, Ymkje Stienstra, et al.
The Journal of Infectious Diseases|July 1, 1994
Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical Trials Group Protocol 151M A Jacobson, F Kramer, Y Bassiakos, et al.
The New England Journal of Medicine|March 16, 1995
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials GroupS A Bozzette, D M Finkelstein, S A Spector, et al.
Pageof 41

Showing results (151-160 of 402) with videos related to

Sort By:
Pageof 41
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000
A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individualsC M Marra, P Boutin, J C McArthur, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 3, 2008
Hybrid approach for complex coronary artery and valve disease: a clinical follow-up studyJ O J Peels, G A J Jessurun, P W Boonstra, et al.
Critical Care (London, England)|July 13, 2006
Hyperglycaemia in critically ill patients: marker or mediator of mortality?Anouk M Corstjens, Iwan C C van der Horst, Jan G Zijlstra, et al.
Immunologic Research|January 19, 2022
Analysis of PD-1, PD-L1, and T-cell infiltration in angiosarcoma pathogenetic subgroupsT Tomassen, M E Weidema, M H S Hillebrandt-Roeffen, et al.
International Journal of Cardiology|January 16, 2007
One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The Glucose-insulin-potassium study IISaman Rasoul, Jan Paul Ottervanger, Jorik R Timmer, et al.
BMJ (Clinical Research Ed.)|July 5, 2022
Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysisRuben J Eck, Tessa Elling, Alex J Sutton, et al.
American Heart Journal|July 2, 2005
Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2)Iwan C C van der Horst, Jorik R Timmer, Jan Paul Ottervanger, et al.
Intensive Care Medicine|February 16, 2006
Mean glucose level is not an independent risk factor for mortality in mixed ICU patientsJack J M Ligtenberg, Sofie Meijering, Ymkje Stienstra, et al.
The Journal of Infectious Diseases|July 1, 1994
Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical Trials Group Protocol 151M A Jacobson, F Kramer, Y Bassiakos, et al.
The New England Journal of Medicine|March 16, 1995
A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials GroupS A Bozzette, D M Finkelstein, S A Spector, et al.
Pageof 41